Parametrica Management LTD Novavax Inc Transaction History

Parametrica Management LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$36.28 - $75.29 $346,074 - $718,191	-9,539 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$69.73 - $142.9 $539,222 - $1.11 Million	7,733 Added 428.18%	9,539 $703,000
Q4 2021 Feb 15, 2022	SELL	$134.56 - $217.97 $7.87 Million - $12.7 Million	-58,490 Reduced 97.0%	1,806 $258,000
Q3 2021 Nov 12, 2021	BUY	$177.8 - $270.58 $8.91 Million - $13.6 Million	50,096 Added 491.14%	60,296 $12.5 Million
Q2 2021 Aug 13, 2021	BUY	$121.0 - $257.67 $1.08 Million - $2.3 Million	8,917 Added 695.01%	10,200 $2.17 Million
Q1 2021 May 14, 2021	BUY	$112.98 - $319.93 $144,953 - $410,470	1,283 New	1,283 $222,000

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $704M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Parametrica Management LTD, based on Form 13F filings with the SEC.

Stay updated on Parametrica Management LTD with notifications on news.